Is low-dose Quetiapine (Seroquel) a treatment option for insomnia in a 16-year-old female with a possible mood disorder?

Quetiapine (Seroquel) is not recommended as a first-line treatment for insomnia in adolescents, including a 16-year-old female with a possible mood disorder. For adolescents with insomnia, especially those with mood concerns, it's preferable to start with non-pharmacological approaches such as sleep hygiene education, cognitive behavioral therapy for insomnia (CBT-I), and addressing any underlying mood issues with appropriate therapy. If medication is deemed necessary, options like melatonin might be considered before atypical antipsychotics. Quetiapine, even at low doses, carries risks including metabolic effects (weight gain, lipid and glucose abnormalities), sedation, and potential for long-term dependence. While quetiapine is sometimes used off-label for insomnia in adults, this practice is particularly concerning in adolescents whose brains are still developing. The risk-benefit ratio generally doesn't favor using quetiapine primarily for sleep in this age group. A comprehensive evaluation by a child/adolescent psychiatrist would be more appropriate to properly diagnose and treat both the mood disorder and associated sleep problems with safer interventions.